Regulus Therapeutics (RGLS) - Shares outstanding

Number of shares outstanding as of March 2025 : 56,346,033

According to Regulus Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 56,346,033. At the end of 2024 the company had 65,471,132 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Regulus Therapeutics from 2022 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	65.47 M	233.55%
2023	19.62 M	16.56%
2022	16.83 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
GlaxoSmithKline GSK	2,038,500,000	3,517.82%	🇬🇧 UK
Sanofi SNY	2,502,800,000	4,341.84%	🇫🇷 France
Biogen BIIB	145,600,000	158.40%	🇺🇸 USA
AstraZeneca AZN	3,100,000,000	5,401.72%	🇬🇧 UK
Alnylam Pharmaceuticals ALNY	128,590,000	128.21%	🇺🇸 USA
Sangamo Therapeutics SGMO	201,699,000	257.96%	🇺🇸 USA
Bristol-Myers Squibb BMY	2,028,000,000	3,499.19%	🇺🇸 USA
Dicerna Pharmaceuticals DRNA	73,916,400	31.18%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Regulus Therapeutics (RGLS)

Number of shares outstanding as of March 2025 : 56,346,033